Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

August 01, 1988; Volume 246,Issue 2
  • You have access
    Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
    G Malfatto, A Zaza, M Forster, B Sodowick, P Danilo and M R Rosen
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 419-426;
  • You have access
    Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
    T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;
  • You have access
    Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
    G A Kopia, E H Ohlstein and R R Ruffolo
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 434-440;
  • You have access
    Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
    K L Preston, G E Bigelow and I A Liebson
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 441-448;
  • You have access
    Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
    P J Tiseo, E B Geller and M W Adler
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 449-453;
  • You have access
    Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay.
    L D Gruenke, K Konopka, D R Koop and L A Waskell
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 454-459;
  • You have access
    Mechanism of ochratoxin A transport in kidney.
    P P Sokol, G Ripich, P D Holohan and C R Ross
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 460-465;
  • You have access
    Cardiovascular effects of cocaine in conscious dogs: importance of fully functional autonomic and central nervous systems.
    R D Wilkerson
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 466-471;
  • You have access
    Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor.
    S M Owens, M Zorbas, D L Lattin, M Gunnell and M Polk
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 472-478;
  • You have access
    Neuropeptide Y stimulates renal prostaglandin synthesis in the isolated rat kidney: contribution of Ca++ and calmodulin.
    M M el Din and K U Malik
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 479-484;
  • You have access
    Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Y F Chen, H K Jin, R Paul and S Nagahama
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 485-492;
  • You have access
    Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
    S Batzri, O Brugada, J W Harmon and N M Rich
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 493-499;
  • You have access
    Interaction of morphine with intrathecally administered calcium and calcium antagonists: evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice.
    F Lux, S P Welch, D A Brase and W L Dewey
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 500-507;
  • You have access
    Influence of dynorphin (1-13) on spinal reflexes in the rat.
    R M Caudle and L Isaac
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 508-513;
  • You have access
    Pyrethroid insecticides evoke neurotransmitter release from rabbit striatal slices.
    J T Eells and M L Dubocovich
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 514-521;
  • You have access
    Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney.
    R Loutzenhiser, K Hayashi and M Epstein
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 522-528;
  • You have access
    C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.
    P J Privitera, A R Granata, M D Underwood, T E Gaffney and D J Reis
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 529-533;
  • You have access
    Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
    S B Hwang, M H Lam, A W Alberts, R L Bugianesi, J C Chabala and M M Ponpipom
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 534-541;
  • You have access
    Role of arachidonate metabolites in C5a-induced bronchoconstriction.
    J F Regal
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 542-547;
  • You have access
    Reversal of inhibition of prolactin secretion in cultured pituitary cells by muscarinic antagonists.
    J E Beach, R C Smallridge, P K Chiang and H G Fein
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 548-552;
  • You have access
    Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
    S E Moroi-Fetters, N H Neff and M Hadjiconstantinou
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 553-557;
  • You have access
    Ethanol potentiation of GABAergic transmission in cultured spinal cord neurons involves gamma-aminobutyric acidA-gated chloride channels.
    A K Mehta and M K Ticku
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 558-564;
  • You have access
    Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally.
    G E DeLander and J J Wahl
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 565-570;
  • You have access
    Noradrenergic denervation alters serotonin2-mediated behavior but not serotonin2 receptor number in rats: modulatory role of beta adrenergic receptors.
    A S Eison, F D Yocca and G Gianutsos
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 571-577;
  • You have access
    Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions.
    P J Chiu, A Barnett, M Siegel, A D Brown and C Gerhart
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 578-584;
  • You have access
    Inhibition of tracheal smooth muscle contraction and myosin phosphorylation by ryanodine.
    W T Gerthoffer, K A Murphey and M A Khoyi
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 585-590;
  • You have access
    Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs.
    M F Doursout, J E Chelly, C J Hartley, J Szilagyi, J L Montastruc and J P Buckley
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 591-596;
  • You have access
    Natriuretic action of neurohypophysial peptides: effects of agonists and antagonists and implication of natriuretic receptor.
    W Y Chan and V J Hruby
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 597-602;
  • You have access
    Renal prostaglandins and natriuretic action of oxytocin and vasopressin in rats.
    W Y Chan
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 603-609;
  • You have access
    Discriminative-stimulus effects of adenosine analogs: mediation by adenosine A2 receptors.
    R D Spealman and V L Coffin
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 610-618;
  • You have access
    Cigarette brand-switching: effects on smoke exposure and smoking behavior.
    J P Zacny and M L Stitzer
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 619-627;
  • You have access
    The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
    T J Verbeuren, L L Zonnekeyn, J F Prost, C Rochat, J R Thomas and A G Herman
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 628-634;
  • You have access
    Bradykinin-induced contraction is inhibited by tiaramide, an anti-inflammatory drug, with an inhibition of increase in intracellular free calcium.
    N Nakahata and H Nakanishi
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 635-640;
  • You have access
    Relaxant effect of amiloride on canine tracheal smooth muscle.
    I K Krampetz and R Bose
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 641-648;
  • You have access
    Effect of chronic morphine treatment on thyrotropin and prolactin levels and acute hormone responses in the rat.
    P Rauhala, P T Männistö and R K Tuominen
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 649-654;
  • You have access
    Doxorubicin: mechanism of cardiodepressant actions in guinea pigs.
    K Hagane, T Akera and J R Berlin
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 655-661;
  • You have access
    Prejunctional alpha adrenoceptor and angiotensin receptor function in isolated human, monkey and dog arteries.
    N Toda, S Inoue and H Okunishi
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 662-666;
  • You have access
    Cardiotonic action of [8]-gingerol, an activator of the Ca++-pumping adenosine triphosphatase of sarcoplasmic reticulum, in guinea pig atrial muscle.
    M Kobayashi, Y Ishida, N Shoji and Y Ohizumi
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 667-673;
  • You have access
    Cardioprotective action of alpha-blocking agents, phentolamine and bunazosin, on hypoxic and reoxygenated myocardium.
    S Takeo, K Tanonaka, M Matsumoto, K Miyake and R Minematsu
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 674-681;
  • You have access
    Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
    M Taglialatela, S Amoroso, G Kaparos, F Maurano, G F Di Renzo and L Annunziato
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 682-688;
  • You have access
    Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. II. Effect of the inhibition of the Na+-Ca++ exchange by amiloride.
    M Taglialatela, S Amoroso, L M Canzoniero, G F Di Renzo and L Annunziato
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 689-694;
  • You have access
    Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
    V Joly, B Pangon, N Brion, J M Vallois and C Carbon
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 695-700;
  • You have access
    Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats.
    P B Clarke, D S Fu, A Jakubovic and H C Fibiger
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 701-708;
  • You have access
    Reduced function of the stimulatory GTP-binding protein in beta adrenoceptor-adenylate cyclase system of femoral arteries isolated from spontaneously hypertensive rats.
    M Asano, K Masuzawa, T Matsuda and T Asano
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 709-718;
  • You have access
    Effect of the calcium entry blocker NB-818 on cerebral blood flow after unilateral carotid occlusion in the Mongolian gerbil.
    M Nishikibe
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 719-725;
  • You have access
    Inhibitory actions of tachykinins and neurokinins on release of somatostatin-like immunoreactivity from the isolated perfused rat stomach.
    Y N Kwok, C H McIntosh, H Sy and J C Brown
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 726-731;
  • You have access
    Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
    G D Phillips, P Rafferty, C Robinson and S T Holgate
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 732-738;
  • You have access
    Receptors for tachykinins in canine intestine circular muscle.
    M J Muller, H Sato, P Bowker and E E Daniel
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 739-744;
  • You have access
    Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
    M Hamon, C M Fattaccini, J Adrien, M C Gallissot, P Martin and H Gozlan
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 745-752;
  • You have access
    Lithium clearance as an indicator of proximal tubular sodium handling during furosemide diuresis.
    S Christensen, M Shalmi and J S Petersen
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 753-757;
  • You have access
    Albendazole sulfonation by rat liver cytochrome P-450c.
    H Souhaili-El Amri, O Mothe, M Totis, C Masson, A M Batt, P Delatour and G Siest
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 758-764;
  • You have access
    Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice.
    D G Hoyt and J S Lazo
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 765-771;
  • You have access
    Comparative effects of alpha-1 and alpha-2 adrenoceptors in modulation of coronary flow during exercise.
    J R Strader, P A Gwirtz and C E Jones
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 772-778;
  • You have access
    Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells.
    N Mahy, M Woolkalis, K Thermos, K Carlson, D Manning and T Reisine
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 779-785;
  • You have access
    WHR 1049, a potent metabolite of lidamidine, has antidiarrheal and antimotility effects on the small intestine in rats.
    E Y Eaker, G B Bixler and J R Mathias
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 786-789;
  • You have access
    Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
    R J Shebuski, J M Smith, B L Storer, J R Granett and P J Bugelski
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 790-796;
  • You have access
    Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat.
    A Mattia, K L Marquis, A P Leccese, E E el-Fakahany and J E Moreton
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 797-802;
  • You have access
    Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action.
    K W Gee, M B Bolger, R E Brinton, H Coirini and B S McEwen
    Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 803-812;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 246, Issue 2
1 Aug 1988
  • Table of Contents
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics